Development of New Drugs by the US Pharmaceutical Industry

/in /by

This paper is on Development of New Drugs by the US Pharmaceutical Industry. The concept of creating a vaccine, identifying how new vaccines are distributed, researched and funded.

Development of New Drugs by the US Pharmaceutical Industry

The concept of creating a vaccine, identifying new vaccines are distribution, research and funding. Also the research on prior pandemics and vaccine development and distribution. Is the COVID vaccine development following similar trends or is the drug being rush ed as some people are speculating? Are pharmaceuticals being funded in a different fashion the prior or standard practices etc. Use graphs or diagrams -just not in excess. At least 20 PEER-REVIEWED sources. Additionally, running headers and page numbers need to be included. Everything APA standard.

More details;

Current Model for Financing Drug Development: From Concept Through Approval

The cost of developing a new drug has been estimate to be more than $1 billion. Development of this scale involves multiple financing mechanisms, as well as the involvement of numerous partners throughout the process. As background for the workshop discussions, Dr. Caskey provided an overview of the current financial landscape at various stages of drug development, including the investors at each stage and the current state of investments, and put forth several suggestions for ways to facilitate drug development.

INVESTORS IN DRUG DEVELOPMENT

The principal investors in drug development differ at each stage. While basic discovery research is fund primarily by government and by philanthropic organizations, late-stage development is fund mainly by pharmaceutical companies or venture capitalists. The period between discovery and proof of concept, however, is consider extremely risky and therefore has been difficult to fund. Several initiatives have been take n to overcome this funding gap.

Early-and Late-Stage Development

Historically, the largest government investments in basic drug discovery research from the National Institutes of Health (NIH).